LifeStance Health appoints Teresa DeLuca to board of directors

LifeStance Health Group, Inc.

Board appointed Teresa DeLuca as a director effective March 12, 2024.
No departures or other board changes announced.
Appointment fills a board vacancy or adds new director; no material compensation terms disclosed.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Teresa DeLuca

director

LFST · LifeStance Health Group, Inc.

Effective: 2024-03-12
Filed: March 12, 2024, 7:59 PM ET

On March 12, 2024, the Company’s Board of Directors (the “Board”) appointed Teresa DeLuca as a director of the Company, effective immediately.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Teresa DeLuca was appointed as director at LifeStance Health Group, Inc..

Action: appointed
Role: director

Exact text from the filing

On March 12, 2024, the Company’s Board of Directors (the “Board”) appointed Teresa DeLuca as a director of the Company, effective immediately.

View on SEC.gov

LifeStance Health Group, Inc. filing history →

Source: SEC EDGAR

accession 0000950170-24-029684

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.